Skip to main content
. 2023 Jan 17;13:1093607. doi: 10.3389/fimmu.2022.1093607

Figure 4.

Figure 4

(A) Pancreatic-targeting exosomes-based dual delivery biosystem for pancreatic immunotherapy and reprogramming tumor microenvironment (Reprinted with the permission from Ref. 128); (B) The Scheme of NEs-Exos system for glioma immunotherapy (Reprinted with the permission from Ref. 147); (C) The preparation scheme and therapeutic process of Exo@DOX–EPT1 for oral squamous cell carcinoma (Reprinted with the permission from Ref. 136). iEXO-OXA, Exosomes losding oxaliplatin; ICD, immunogenic cell death; EPT1, Endoperoxide derivative; NPs, Nanoparticles; DOX, Doxorubicin; ROS, reactive oxygen; Ce6, Chlorin e6.